Background. Incidental neoplastic lesions are occasionally found in renal biopsy specimens, but there is no evidence to indicate how they should be managed. Methods. A retrospective review was made of the management and clinical course of patients in whom an unsuspected neoplasm had been found in a renal biopsy. Results. In 11 880 biopsies taken over 22 years, there were incidental neoplasms in 25 (0.2%). Twenty-three of the 25 patients were men, and the median age was 59 years (range, 42-83 years). All had chronic renal damage, with a median index of chronic damage of 37% (range, 10-83%; normal ¼ 0%). Twenty-two neoplasms were papillary, two were clear cell renal carcinomas and one was in situ carcinoma in a collecting duct. The two clear cell carcinomas, three papillary neoplasms with residual masses after biopsy and the two papillary neoplasms in renal allografts were resected by nephrectomy or partial nephrectomy. Seven patients without resection were imaged with computerized tomography, six with magnetic resonance imaging and three with ultrasound scanning. Two were not imaged. None of the 11 patients who died, nor any of the other 14, had evidence of renal cell carcinoma at death or last follow-up respectively, at median 3.6 years after biopsy (range, 1 month-18.2 years). Conclusions. When an incidental neoplasm is found, the pathological type should be defined, and imaging should be performed. Surgery should be considered in patients in whom there is a neoplasm of any type detectable by imaging, and limited resection may be possible. Neoplasms that are undetectable with imaging cannot be resected as the site of the lesion is unknown. We suggest surveillance of these, but whether this is necessary is undetermined. There is no evidence whether neoplasms undetectable with imaging in renal allografts require aggressive treatment.
Introduction
Incidental discovery of a neoplasm is rare in a renal biopsy not performed to investigate a renal mass. There is no published evidence about the frequency and significance of this finding, and it is unclear what practical course should be taken in management. We reviewed all patients in our unit who had such a finding, to determine its frequency, the clinical management and the eventual outcome.
Methods
During the 22 years from 1982-2003 inclusive, a note was made of renal biopsy specimens that contained a neoplasm, excluding (1) biopsies of masses in or near the kidney detected before the biopsy, (2) biopsies in patients known to have a neoplasm outside the kidney and in whom the neoplasm in the renal biopsy was metastatic and (3) biopsies containing a haemangioma or a renomedullary interstitial cell neoplasm, formerly called medullary fibroma. Biopsies were reviewed to determine the size and characteristics of the neoplasm [1] , and to measure the index of chronic damage [2] . This is a morphometric method that uses an interactive image analysis system to express the extent of global glomerulosclerosis, tubular atrophy and interstitial fibrosis as a proportion of cortical cross-sectional area. The index is 0% in a kidney without chronic damage, and can be any value up to 100%. Nephrectomy specimens of biopsied kidneys were sectioned at about 3 mm intervals and any lesions were taken for microscopy. These were also reviewed. A study of clinical notes was made to find the method of management at the time of the biopsy, and whether the patient was alive or dead, and if dead, cause of death. Reports of imaging investigations were reviewed for the mention of renal masses or metastatic disease.
Results
There were 11 880 renal biopsies. These consisted of 10 025 percutaneous needle biopsies, including 3613 of allografts and 1855 wedge biopsies of allografts at implantation. Neoplasms were found in 25 specimens (0.2%) ( Table 1 ). The median age of patients was 59 years (range, 42-83 years). Twenty-three of the 25 patients were male. All had chronic renal damage in the renal biopsy (median index of chronic damage, 37%, range, 10-83%). Twenty-one of the 25 neoplasms were under 1 mm diameter on the sections, although most contacted at least one aspect of the specimen and so did not appear completely included in the biopsy. All but three were papillary neoplasms, sometimes with foamy macrophages and psammoma bodies. The cells were chromophilic rather than clear, and nearly all were amphiphilic or eosinophilic rather than basophilic (Figures 1 and 2) . Three neoplasms were different. In patients 3 and 21, these were solid, with eosinophilic or clear cells, indicative of renal cell carcinoma, traditionally called clear cell type [1] ( Figure 3) . In Patient 24, there was in situ neoplasia in a collecting duct [3] .
Fifteen of the 25 patients had ultrasonography (US) of the kidneys before biopsy, and 22 had renal imaging immediately after the biopsy (Table 2) . Imaging included computed tomography (CT) with contrast (11 patients), or in patients who were considered high risk for contrast study, magnetic resonance imaging (MRI) (7 patients). Four had US alone.
Renal masses were reported in six patients, bilaterally in one. Five of these, Patients 3, 12, 13, 16 and 21, had nephrectomy or partial nephrectomy shortly after the biopsy. In the other, Patient 20, an ill-defined mass was reported, possibly a haematoma, and surveillance by US at 6-monthly intervals showed that this was unchanged in size at the last examination. Patients 10 and 17, both with renal allografts, had nephrectomy, although there was no detectable mass. The other one with a renal allograft, Patient 4, and the other 16 patients did not have nephrectomy. These included Patient 24, who was followed with renal imaging, cystoscopy and ureteroscopy, which showed no abnormality, and regular urine cytopathological examination, which showed malignant transitional cells in the urine in the first 5 months following biopsy, but not at any time after that. Because the site of origin of the malignant cells could not be identified initially and they were later undetectable, no resection was performed.
In six of the seven nephrectomy or partial nephrectomy specimens, there were multiple neoplasms. In the other one, Patient 21, there was a clear cell carcinoma, as seen in the biopsy. The multiple neoplasms were papillary neoplasms in five patients, all under 5 mm diameter, and in the other one (Patient 3), renal cell carcinomas, with a mixture of clear, eosinophilic and spindle cells. No patient had evidence of invasion through the renal capsule or spread to lymph nodes. There was no family history of renal cancer in patients with multiple neoplasms, nor any other features to suggest inherited syndromes.
At the time of review, 11 patients were dead. The causes of death were myocardial infarction in three patients, respiratory failure in two, and in one each, stroke, adenocarcinoma of stomach, adenocarcinoma of prostate, sepsis, liver failure and renal failure. In none of the patients was the cause of death related to renal cell carcinoma, although two died of histologically proven disseminated adenocarcinomas of other organs, Patients 5 and 19, and two had paraproteins with systemic effects, Patients 23 and 25.
Nine patients were under surveillance by imaging. Those who had not had CT or MRI for 5 years had further US of the kidneys. Apart from Patient 20, these patients showed no evidence of a renal mass or metastatic carcinoma. The remaining five were Patients 12 and 21, who had had nephrectomy, Patients 10 and 17, who had had allograft nephrectomy and Patient 2, who had moved elsewhere. They were examined regularly and there was no clinical evidence of malignancy. The duration of follow-up to the time of review, or to death, ranged from 1 month to 18.2 years, with a mean of 4.8 years and a median of 3.6 years.
Discussion
No similar series has been published reporting the incidental finding of neoplasms in renal biopsies. We show that this finding is rare (0.2%, or one in 500 biopsies), and occurs most commonly in men aged over 50 years with renal impairment and a marked amount of chronic renal damage. Most neoplasms appeared tiny and of the papillary pattern [1] . Assigning these neoplasms to two different types of papillary neoplasms, as suggested by Delahunt and Eble [4, 5] , was not straightforward, and because many experts do not carry out subtyping [3, 6] , this was not done. The distinction between papillary adenomas and papillary carcinomas of the kidney is, to some extent, arbitrary and based on size, in the absence of evidence of malignancy, such as capsular invasion. Lesions no more than 5 mm in diameter are considered adenomas, but they are otherwise similar to carcinomas [1] . Papillary adenomas are the commonest neoplasms found in the kidney, and are often bilateral and multiple, as we found in several of the nephrectomy specimens. They occur more commonly with increasing age, and are found at autopsy in 10% of people under 40 years and in 40% of those over 70 years [1] .
In contrast, all non-papillary neoplasms are considered malignant, whatever their size, if they consist Cause of death of tx donor. as, ankylosing spondylitis; bp, hypertension; dm, diabetes mellitus; f, female; gn, glomerulonephritis; hu, haematuria; ich, intracerebral haemorrhage; ihd, ischaemic heart disease; m, male; ns, nephrotic syndrome; pu, proteinuria; ra, renal artery; rf, renal failure; sah, subarachnoid haemorrhage; tx, transplant. of clear or eosinophilic or chromophobe cells [1] . The lesions in Patients 3 and 21 were not papillary and were considered malignant. Residual masses were detected by imaging after biopsy, and their nephrectomy specimens confirmed renal cell carcinomas, multiple and bilateral in one patient. The management of patients with similar findings appears straightforward. The finding of in situ carcinoma in a collecting duct in Patient 24 was followed by investigations to detect transitional neoplasia in the urinary tract [3] , and there was cytopathological evidence of this for some time after the biopsy. Management of similar patients with suspected transitional malignancy requires investigations different from those with suspected renal cell neoplasia.
The management of papillary neoplasms is still a problem. Renal imaging is necessary to determine their size, because those over 5 mm diameter are considered malignant. The limit of size of lesions detectable by US is often considered about 5 mm, but there is no definite evidence for this, and the limit of detection may vary between centres. CT and MRI may be more sensitive, but again this may vary. In most patients in the current series, no mass was detected after biopsy, and in nearly all, no surgery was considered. The two exceptions were Patients 10 and 17, whose renal allografts contained papillary neoplasms. There is no published guidance on management of such patients, and surveillance, rather than immediate nephrectomy, was chosen in Patient 4, who also had a neoplasm in a graft. Because papillary neoplasms are so common [1] , there is a likelihood that many have been transplanted unwittingly. Definite renal cell carcinomas are occasionally noted in kidneys that are potential grafts, and the kidneys are then discarded [7] . Tiny neoplasms are not likely to be seen in potential grafts, especially if they are away from the capsular surface, as many were in kidneys in our series (Table 1) . Papillary carcinomas probably arise from adenomas [3] . There is accordingly a theoretical risk of progression of small papillary neoplasms in renal allografts into papillary carcinomas, but there is no evidence about how commonly this occurs. There is undoubtedly an increased incidence of neoplasms in immunosuppressed patients, including renal carcinomas and papillary neoplasms, although these are particularly in the patients' own kidneys, rather than in grafts [8] [9] [10] [11] . This suggests that the risk of progression of neoplasms in grafts may not be especially high.
In future, cytogenetic analysis may help to determine the nature of some renal neoplasms detected incidentally [1] , but this was not available to us. In any event, this is likely to be difficult on the extremely small amounts of tissue available, and cannot distinguish papillary adenomas from papillary carcinomas [1] . We suggest that when an incidental neoplasm is found in a renal biopsy, the pathological type is defined, and detailed imaging undertaken. Surgery should be considered in patients in whom there is a neoplasm of any histological type detectable by imaging, because it is likely to be over 5 mm in diameter. Limited resection may be possible, rather than nephrectomy. This decision must take into account co-existing disease and whether the patient is fit for surgery. Neoplasms that are not detected with imaging cannot be resected by limited nephrectomy as the site of the lesion is unknown. We suggest surveillance of these, but whether this is necessary is undetermined. There is no evidence whether neoplasms that are undetectable by imaging in renal allografts require aggressive treatment.
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